White; Christine A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for White; Christine A..The latest application filed is for "treatment of diffuse large-cell lymphoma with anti-cd20 antibody".

Company Profile

1.7.7

White; Christine A. - Rancho Santa Fe CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment of diffuse large-cell lymphoma with anti-CD20 antibody Grant 10,400,043 - White , et al. Sep	2019-09-03
Treatment Of Diffuse Large-cell Lymphoma With Anti-cd20 Antibody App 20180118844 - White; Christine A. ; et al.	2018-05-03
Treatment Of Diffuse Large-cell Lymphoma With Anti-cd20 Antibody App 20170037139 - White; Christine A. ; et al.	2017-02-09
Treatment of diffuse large-cell lymphoma with anti-CD20 antibody Grant 9,504,744 - White , et al. November 29, 2	2016-11-29
Treatment Of Diffuse Large-cell Lymphoma With Anti-cd20 Antibody App 20140302018 - White; Christine A. ; et al.	2014-10-09
Treatment of diffuse large-cell lymphoma with anti-CD20 antibody Grant 8,821,873 - White , et al. September 2, 2	2014-09-02
Treatment Of Diffuse Large-cell Lymphoma With Anti-cd20 Antibody App 20140030263 - White; Christine A. ; et al.	2014-01-30
Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies Grant 8,206,711 - White , et al. June 26, 2	2012-06-26
Treatment of Chronic Lymphocytic Leukemia using Anti-CD20 Antibodies App 20100080769 - Grillo-Lopez; Antonio J. ; et al.	2010-04-01
Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody Grant 7,682,612 - White , et al. March 23, 2	2010-03-23
Clinical Parameters for Determining Hematologic Toxicity Prior to Radioimmunotherapy App 20070148714 - Raestetter; William ; et al.	2007-06-28
Clinical parameters for determining hematologic toxicity prior to radioimmunotherapy Grant 7,195,750 - Raestetter , et al. March 27, 2	2007-03-27
New clinical parameters for deteriming hematologic toxicity prior to radioimmunotherapy App 20030211038 - Rastetter, William H. ; et al.	2003-11-13
Clinical parameters for determining hematologic toxicity prior to radioimmunotheraphy Grant 6,451,284 - Raestetter , et al. September 17, 2	2002-09-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.